A celebrity hairdresser who now styles the stars says he rebuilt his life after losing his vision – even though the ...

Noguchi FS formula error was 0.280 D in 486 eyes, LAL piggyback cut residual cylinder to 0.1 D, and Yamane and Gore-Tex fixation showed distinct complication profiles.

Glaukos Corporation (NYSE:GKOS) reported three-year trial results for its non-invasive keratoconus treatment while ...

Arun C. Gulani, MD, introduces a keratoconus classification based on what prevents vision: visual, structural, or salvage.

Glaukos recently reported positive topline results from a long-term Phase 3 extension study of Epioxa, showing three-year ...

Glaukos Corporation ( GKOS ), an ophthalmic pharmaceutical and medical technology company, announced positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating the ...

Glaukos Corp. ( GKOS) on Wednesday reported three-year results from a Phase 3 extension study evaluating Epioxa, its epithelium-on corneal cross-linking therapy for keratoconus. Keratoconus is a ...

Glaukos Corporation (NYSE: GKOS) announced results from a long-term Phase 3 extension study evaluating its Epioxa corneal cross-linking therapy for keratoconus, showing sustained efficacy and safety ...

Glaukos said on Wednesday patients treated with its ​late-stage eye disease therapy maintained improvements in vision and ...

Glaukos Corporation announced positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating the durability, visual outcomes, and safety of Epioxa®, the company's ...

Three-year data demonstrate sustained improvements in corneal shape, meaningful visual acuity gains, and a favorable ...

LV Prasad Eye Institute warns teens and young adults about keratoconus, urging early detection and advanced treatments to stabilize vision.